Subject to meeting the coverage criteria, some BCBS plans cover Zepbound and other GLP-1 agonist weight loss medications, but BCBS Michigan will not offer coverage for GLP-1 weight loss drugs starting from January 1, 2025
While lifestyle modification, pharmacotherapy, and bariatric surgery all improve lipid profiles, the mechanisms and magnitude may differ based on the intervention and individual metabolic factors
Be sure to use a new needle for each injection and follow proper technique to avoid injury or infection
Other Players in the Amylin Arena Aside from Novo, Lilly is also advancing its own suite of amylin hopefuls, the most mature of which is eloralintide, a weekly therapy being tested in combination with tirzepatide in nondiabetic obese people
On top of this comes a second factor: nutrient deficiencies